{ "company_number": "08940397", "name": "Comprehensive Oncology Limited", "url": "/company/08940397", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2014-03-14", "dissolved_on": null, "sic_codes": [ { "code": "86220", "description": "Specialists medical practice activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86220" } ], "registered_address": { "id": 1970849, "url": "/address/1970849", "line1": "OAKMOORE COURT 11C KINGSWOOD ROAD", "line2": "HAMPTON LOVETT", "post_town": "DROITWICH", "county": "WORCESTERSHIRE", "country": "UNITED KINGDOM", "postcode": "WR9 0QH" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08940397", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08940397/accounts/2025-03-31", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1911.00", "debtors": "559908.00", "cash_bank_in_hand": "109787.00", "current_assets": "669695.00", "creditors_due_within_one_year": "22460.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "647235.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "649146.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "649046.00", "shareholder_funds": "649146.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2025.zip" }, { "url": "/company/08940397/accounts/2024-03-31", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2801.00", "debtors": "533732.00", "cash_bank_in_hand": "63740.00", "current_assets": "597472.00", "creditors_due_within_one_year": "34162.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "563310.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "566111.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "566011.00", "shareholder_funds": "566111.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2024.zip" }, { "url": "/company/08940397/accounts/2023-03-31", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2533.00", "debtors": "507933.00", "cash_bank_in_hand": "53059.00", "current_assets": "560992.00", "creditors_due_within_one_year": "87764.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "473228.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "475761.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "475661.00", "shareholder_funds": "475761.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2023.zip" }, { "url": "/company/08940397/accounts/2022-03-31", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1419.00", "debtors": "234788.00", "cash_bank_in_hand": "172445.00", "current_assets": "407233.00", "creditors_due_within_one_year": "20300.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "386933.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "388352.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "388252.00", "shareholder_funds": "388352.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2022.zip" }, { "url": "/company/08940397/accounts/2021-03-31", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1973.00", "debtors": "216795.00", "cash_bank_in_hand": "134905.00", "current_assets": "351700.00", "creditors_due_within_one_year": "19531.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "332169.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "334142.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "334042.00", "shareholder_funds": "334142.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2021.zip" }, { "url": "/company/08940397/accounts/2020-03-31", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1091.00", "debtors": "219932.00", "cash_bank_in_hand": "77127.00", "current_assets": "297059.00", "creditors_due_within_one_year": "10597.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "286462.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "287553.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "287453.00", "shareholder_funds": "287553.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2020.zip" }, { "url": "/company/08940397/accounts/2019-03-31", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1636.00", "debtors": "159631.00", "cash_bank_in_hand": "116113.00", "current_assets": "275744.00", "creditors_due_within_one_year": "26125.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "249619.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "251255.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "251155.00", "shareholder_funds": "251255.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2019.zip" }, { "url": "/company/08940397/accounts/2018-03-31", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "2455.00", "debtors": "156509.00", "cash_bank_in_hand": "67175.00", "current_assets": "223684.00", "creditors_due_within_one_year": "15007.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "208677.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "211132.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "211032.00", "shareholder_funds": "211132.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/08940397/accounts/2017-03-31", "made_up_date": "2017-03-31", "period_start": "2017-03-31", "period_end": "2017-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "2561.00", "debtors": "97589.00", "cash_bank_in_hand": "83841.00", "current_assets": "181430.00", "creditors_due_within_one_year": "23847.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "157583.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "160144.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "160044.00", "shareholder_funds": "160144.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2017.zip" }, { "url": "/company/08940397/accounts/2016-03-31", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3726.00", "debtors": "8909.00", "cash_bank_in_hand": "89918.00", "current_assets": "98827.00", "creditors_due_within_one_year": "16620.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "82207.00", "total_assets_less_current_liabilities": "85933.00", "net_assets_liabilities": "84083.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "83983.00", "shareholder_funds": "84083.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2016.zip" }, { "url": "/company/08940397/accounts/2015-03-31", "made_up_date": "2015-03-31", "period_start": "2015-03-31", "period_end": "2015-03-31", "entity_name": "Comprehensive Oncology Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "499.00", "debtors": "5079.00", "cash_bank_in_hand": "49692.00", "current_assets": "54771.00", "creditors_due_within_one_year": "26544.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "28227.00", "total_assets_less_current_liabilities": "28726.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "28626.00", "shareholder_funds": "28726.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08940397/filing-history" }, "confirmation_statement": { "next_due": "2027-03-28", "last_made_up": "2026-03-14" }, "officers": [], "psc": [ { "name": "Sandhuni Shanika Correa", "kind": "individual-person-with-significant-control", "person_url": "/person/4460780", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2020-05-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Dr Peter Correa", "kind": "individual-person-with-significant-control", "person_url": "/person/3945374", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }